⚠️
This device has not received regulatory clearance
This listing is based on publicly available information and has not been verified by the manufacturer or any regulatory authority.
ALT-006187Pre-approval
repetitive Transcranial Magnetic Stimulation
Peking University Sixth Hospital · Sponsor
Regulatory Pipeline
✓
Proof of Concept✓
Development3
Clinical Trial4
Pre-submission5
Submitted6
Under Review7
ClearedAll identifiers (2)
Aletia (canonical)
ALT-006187ClinicalTrials.gov (primary)
NCT07173920Trial signal only — manufacturer hasn't claimed this listing yet.
The trial data below was imported from ClinicalTrials.gov. If you represent Peking University Sixth Hospital, you can claim this listing to add funding, team, and contact details.
Claim this listing →Clinical Trial Signal
NCT07173920 ↗
recruiting
A Single-Center, Double-Blind, Randomized, Placebo-Controlled Clinical Study on the Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation (rTMS) Under Precise Localization for Relieving Motor Symptoms of Tardive Dyskinesia
Phase: na62 enrolledCN
Investor Interest
Signal to the team that this device is on your radar. Anonymous — the manufacturer sees the count, not your identity.
0
investors